The Safety and Antibody Response of the Nasal COV2 Vaccine Against the SARS-CoV-2 Virus
Clinical trial NCT06851611 · COMPLETED
Trial details
- NCT number
- NCT06851611
- Sponsor
- Rokote Laboratories Finland Oy
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-21
- Primary completion
- 2025-06-25
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.